Ligand Pharmaceuticals
LGND
#3601
Rank
A$5.47 B
Marketcap
A$278.32
Share price
-1.93%
Change (1 day)
45.34%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Total assets

Total assets on the balance sheet as of September 2025 : A$2.22 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's total assets are A$2.22 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Ligand Pharmaceuticals - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31A$1.51 B31.04%
2023-12-31A$1.15 B3.1%
2022-12-31A$1.12 B-37.38%
2021-12-31A$1.78 B1.03%
2020-12-31A$1.77 B-17.02%
2019-12-31A$2.13 B19.3%
2018-12-31A$1.78 B108.22%
2017-12-31A$0.85 B2.99%
2016-12-31A$0.83 B20.86%
2015-12-31A$0.69 B119.02%
2014-12-31A$0.31 B168.57%
2013-12-31A$0.11 B17.01%
2012-12-31A$0.10 B-14.69%
2011-12-31A$0.11 B58.1%
2010-12-31A$74.38 M-52.88%
2009-12-31A$0.15 B-35.04%
2008-12-31A$0.24 B22.61%
2007-12-31A$0.19 B-52.08%
2006-12-31A$0.41 B-3.81%
2005-12-31A$0.42 B0.08%
2004-12-31A$0.42 B1.69%
2003-12-31A$0.42 B-13.58%
2002-12-31A$0.48 B112.38%
2001-12-31A$0.23 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Amgen
AMGN
A$135.70 B 6,003.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
A$0.16 B-92.71%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$124.14 B 5,483.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
A$195.03 B 8,672.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$314.24 B 14,034.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$173.03 B 7,682.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$145.86 B 6,460.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
A$31.71 B 1,326.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$290.28 B 12,956.60%๐Ÿ‡บ๐Ÿ‡ธ USA